<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31698854</article-id>
<article-id pub-id-type="pmc">6888010</article-id>
<article-id pub-id-type="doi">10.3390/ijms20225539</article-id>
<article-id pub-id-type="publisher-id">ijms-20-05539</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Communication</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Changes in Calcium Homeostasis and Gene Expression Implicated in Epilepsy in Hippocampi of Mice Overexpressing <italic>ORAI1</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6797-2101</contrib-id>
<name>
<surname>Majewski</surname>
<given-names>Lukasz</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-05539">1</xref>
<xref ref-type="corresp" rid="c1-ijms-20-05539">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9967-910X</contrib-id>
<name>
<surname>Wojtas</surname>
<given-names>Bartosz</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-20-05539">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maciąg</surname>
<given-names>Filip</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-05539">1</xref>
<xref ref-type="author-notes" rid="fn1-ijms-20-05539">†</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6486-0657</contrib-id>
<name>
<surname>Kuznicki</surname>
<given-names>Jacek</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-05539">1</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-20-05539"><label>1</label>Laboratory of Neurodegeneration, International Institute of Molecular and Cell Biology in Warsaw, Trojdena 4, 02-109 Warsaw, Poland; <email>fmaciag@iimcb.gov.pl</email> (F.M.); <email>jacek.kuznicki@iimcb.gov.pl</email> (J.K.)</aff>
<aff id="af2-ijms-20-05539"><label>2</label>Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology, PAS, Pasteura 3, 02-093 Warsaw, Poland; <email>b.wojtas@nencki.gov.pl</email></aff>
<author-notes>
<corresp id="c1-ijms-20-05539"><label>*</label>Correspondence: <email>lmajewski@iimcb.gov.pl</email></corresp>
<fn id="fn1-ijms-20-05539">
<label>†</label>
<p>Ph.D. student at the Postgraduate School of Molecular Medicine, Warsaw Medical University, 61 Żwirki i Wigury St., 02-091 Warsaw, Poland.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>11</month>
<year>2019</year>
</pub-date>
<volume>20</volume>
<issue>22</issue>
<elocation-id>5539</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>11</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Previously, we showed that the overexpression of <italic>ORAI1</italic> calcium channel in neurons of murine brain led to spontaneous occurrence of seizure-like events in aged animals of transgenic line FVB/NJ-Tg(ORAI1)Ibd (Nencki Institute of Experimental Biology). We aimed to identify the mechanism that is responsible for this phenomenon. Using a modified Ca<sup>2+</sup>-addback assay in the CA1 region of acute hippocampal slices and FURA-2 acetomethyl ester (AM) Ca<sup>2+</sup> indicator, we found that overexpression of <italic>ORAI1</italic> in neurons led to altered Ca<sup>2+</sup> response. Next, by RNA sequencing (RNAseq) we identified a set of genes, whose expression was changed in our transgenic animals. These data were validated using customized real-time PCR assays and digital droplet PCR (ddPCR) ddPCR. Using real-time PCR, up-regulation of hairy and enhancer of split-5 (<italic>Hes-5)</italic> gene and down-regulation of aristaless related homeobox <italic>(Arx)</italic>, doublecortin-like kinase 1 (<italic>Dclk1),</italic> and cyclin-dependent kinase-like 5 (<italic>Cdkl5</italic>, also known as serine/threonine kinase 9 (<italic>Stk9</italic>)) genes were found. Digital droplet PCR (ddPCR) analysis revealed down-regulation of <italic>Arx</italic>. In humans, <italic>ARX</italic>, <italic>DCLK1,</italic> and <italic>CDLK5</italic> were shown to be mutated in some rare epilepsy-associated disorders. We conclude that the occurrence of seizure-like events in aged mice overexpressing <italic>ORAI1</italic> might be due to the down-regulation of <italic>Arx,</italic> and possibly of <italic>Cdkl</italic>5 and <italic>Dclk1</italic> genes. </p>
</abstract>
<kwd-group>
<kwd>epileptic seizures</kwd>
<kwd>ORAI1</kwd>
<kwd>STIM1</kwd>
<kwd>STIM2</kwd>
<kwd>nSOCE</kwd>
<kwd>RNAseq</kwd>
<kwd>RT-PCR</kwd>
<kwd>Cdkl5</kwd>
<kwd>Arx</kwd>
<kwd>Dclk1</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-20-05539" sec-type="intro">
<title>1. Introduction </title>
<p>Store operated calcium entry (SOCE) is a well-described process in non-excitable cells. It was initially known under the name “capacitative Ca<sup>2+</sup> entry” [<xref ref-type="bibr" rid="B1-ijms-20-05539">1</xref>] and has recently been identified also in neurons and called as nSOCE [<xref ref-type="bibr" rid="B2-ijms-20-05539">2</xref>,<xref ref-type="bibr" rid="B3-ijms-20-05539">3</xref>,<xref ref-type="bibr" rid="B4-ijms-20-05539">4</xref>,<xref ref-type="bibr" rid="B5-ijms-20-05539">5</xref>]. In the 1980s, several groups observed a phenomenon that decreasing intracellular [Ca<sup>2+</sup>] activates a transmembrane Ca<sup>2+</sup> current [<xref ref-type="bibr" rid="B6-ijms-20-05539">6</xref>,<xref ref-type="bibr" rid="B7-ijms-20-05539">7</xref>,<xref ref-type="bibr" rid="B8-ijms-20-05539">8</xref>]. During the next two decades of studies, the scientific community established molecular basis of SOCE (reviewed in [<xref ref-type="bibr" rid="B9-ijms-20-05539">9</xref>]). Reduction in [Ca<sup>2+</sup>]<sub>ER</sub> results in activation of plasma membrane Ca<sup>2+</sup> channels that mediate sustained Ca<sup>2+</sup> influx, which is required for a variety of processes. They include maintaining Ca<sup>2+</sup> oscillations [<xref ref-type="bibr" rid="B10-ijms-20-05539">10</xref>], mitochondrial fatty acid oxidation [<xref ref-type="bibr" rid="B11-ijms-20-05539">11</xref>], refilling of Ca<sup>2+</sup> stores, and a few other [<xref ref-type="bibr" rid="B12-ijms-20-05539">12</xref>]. The essential components of SOCE are stromal interaction molecules (STIM1 and STIM2), which function as sensors of the Ca<sup>2+</sup> concentration inside the endoplasmic reticulum (ER) [<xref ref-type="bibr" rid="B13-ijms-20-05539">13</xref>,<xref ref-type="bibr" rid="B14-ijms-20-05539">14</xref>] and ORAIs (ORAI1-3), which are highly selective Ca<sup>2+</sup> channels at the plasma membrane (PM) [<xref ref-type="bibr" rid="B15-ijms-20-05539">15</xref>,<xref ref-type="bibr" rid="B16-ijms-20-05539">16</xref>]. Upon store depletion, STIMs form multimers, which translocate within the endoplasmic reticulum (ER) membrane towards ER-PM junctions, where they activate highly Ca<sup>2+</sup>-selective Ca<sup>2+</sup>-release-activated Ca<sup>2+</sup> channels (CRACs) – ORAIs [<xref ref-type="bibr" rid="B17-ijms-20-05539">17</xref>]. CRAC channels function as hexamer complexes that are composed of potentially multiple ORAI homologues [<xref ref-type="bibr" rid="B18-ijms-20-05539">18</xref>,<xref ref-type="bibr" rid="B19-ijms-20-05539">19</xref>]. Heteromeric channels that are built of endogenous ORAI1 and ORAI2 homologues were found in murine T-cells [<xref ref-type="bibr" rid="B20-ijms-20-05539">20</xref>] and in mast cells [<xref ref-type="bibr" rid="B21-ijms-20-05539">21</xref>], whereas in the enamel cells [<xref ref-type="bibr" rid="B22-ijms-20-05539">22</xref>], dorsal root ganglion (DRG) neurons [<xref ref-type="bibr" rid="B23-ijms-20-05539">23</xref>] and in overexpression studies, ORAI1:ORAI3 multimers were observed [<xref ref-type="bibr" rid="B24-ijms-20-05539">24</xref>]. In murine immune cells, deletion of <italic>Orai1</italic> reduces, whereas deletion of <italic>Orai2</italic> increases SOCE, which indicates that ORAI2 is a less conductive subunit of CRAC channels and enables shaping of the magnitude of SOCE and modulation of the immune response [<xref ref-type="bibr" rid="B20-ijms-20-05539">20</xref>]. Eckstein et al. postulated that ORAI1 and ORAI2 were the main channel subunits of CRAC channels in enamel cells, noting that ORAI3 can act as an inhibitor of ORAI1 in these cells [<xref ref-type="bibr" rid="B22-ijms-20-05539">22</xref>]. In contrast, knockdown of both <italic>Orai1</italic> and <italic>Orai3</italic> in DRG neurons reduced SOCE compared with <italic>Orai1</italic> or <italic>Orai3</italic> knockdown alone [<xref ref-type="bibr" rid="B23-ijms-20-05539">23</xref>]. These manipulations resulted in altered neuronal excitability [<xref ref-type="bibr" rid="B23-ijms-20-05539">23</xref>]. All of these studies have shown that homo- and heteromeric CRAC channels demonstrate different SOCE response, which indicates the importance of the stoichiometry of different ORAI homologues that form the CRAC channel. The expression profile of all three homologues of ORAI varies in different tissues, with the highest level of ORAI1 in immune cells [<xref ref-type="bibr" rid="B25-ijms-20-05539">25</xref>] and ORAI2 in the brain [<xref ref-type="bibr" rid="B26-ijms-20-05539">26</xref>]<italic>,</italic> whereas ORAI3 is abundant in many solid organs and its enhanced gene expression is reported in cancerous cells [<xref ref-type="bibr" rid="B27-ijms-20-05539">27</xref>]. Physiologically, the best-characterized homolog is ORAI1 [<xref ref-type="bibr" rid="B28-ijms-20-05539">28</xref>,<xref ref-type="bibr" rid="B29-ijms-20-05539">29</xref>]. Patients with inherited null or loss of function mutations in <italic>ORAI1</italic> suffer from severe combined immunodeficiency-like disease that is accompanied with chronic, often lethal infections and a variety of non-immunological symptoms [<xref ref-type="bibr" rid="B30-ijms-20-05539">30</xref>,<xref ref-type="bibr" rid="B31-ijms-20-05539">31</xref>]. </p>
<p>Our recently published results indicate that overexpression of <italic>ORAI1</italic> in the murine brain leads to spontaneous occurrence of seizure-like events in aged animals [<xref ref-type="bibr" rid="B32-ijms-20-05539">32</xref>]. In the present study, we extended the phenotyping of the established transgenic line overexpressing <italic>ORAI1</italic> in neurons (FVB/NJ-Tg(ORAI1)Ibd; Nencki Institute of Experimental Biology) by the analysis of Ca<sup>2+</sup> response in the hippocampal CA1 pyramidal cells and RNA sequencing (RNAseq) gene expression profiling. Differential expression of selected genes was next confirmed by real-time PCR and validated using the digital droplet PCR (ddPCR) approach. The observed changes in Ca<sup>2+</sup> signals after glutamate treatment or after ER Ca<sup>2+</sup> store depletion suggest a new potential site of action for ORAI1. Our observations were supported by the identification of a set of genes, whose expression was changed in FVB/NJ-Tg(ORAI1)Ibd mice. For some of these genes, such as cyclin-dependent kinase-like 5 <italic>Cdkl5</italic>, aristaless related homeobox <italic>(Arx)</italic>, and doublecortin-like kinase 1 (<italic>Dclk1)</italic>, mutations in their human homologoues that lead to rare epilepsy-associated disorders were reported. Together, our results provided novel insight into the Ca<sup>2+</sup> dependent actions evoked by CRAC channels that might underlie the occurrence of seizure-like episodes in FVB/NJ-Tg(ORAI1)Ibd mice.</p>
</sec>
<sec id="sec2-ijms-20-05539" sec-type="results">
<title>2. Results</title>
<sec id="sec2dot1-ijms-20-05539">
<title>2.1. Overexpression of ORAI1 in Neurons Leads to Altered Ca<sup>2+</sup> Response in a Modified Ca<sup>2+</sup> Addback Assay in CA1 Hippocampal Region </title>
<p>Acute brain slices of hippocampi of wild-type and transgenic <italic>ORAI1</italic> mice were analyzed by fluorescent imaging. Calcium measurements were performed using Fura-2 acetomethyl ester (AM) indicator that was loaded into the cells by gradual pipetting over the slice with the use of an automated perfusion system. To assess Ca<sup>2+</sup> homeostasis in the <italic>ORAI1</italic> overexpressing neurons, we used a Ca<sup>2+</sup> addback assay that was modified to enable the measurement of Ca<sup>2+</sup> release from the ER [<xref ref-type="bibr" rid="B33-ijms-20-05539">33</xref>]. According to suggestions that were proposed by Amrhein et al. (2019), the results are presented as raw <italic>p</italic>-values [<xref ref-type="bibr" rid="B34-ijms-20-05539">34</xref>]. Also, the asterisks that are commonly used to signify a particular confidence interval are not shown. As shown in <xref ref-type="fig" rid="ijms-20-05539-f001">Figure 1</xref>A, the basal level of Ca<sup>2+</sup> was slightly higher in neurons of transgenic <italic>ORAI1</italic> mice. Stimulation by glutamate led to comparable peaks in all genetic variants tested (<xref ref-type="fig" rid="ijms-20-05539-f001">Figure 1</xref>B,F). However, the time-course of signal decay following the brief pulse of glutamate tended to be slower in <italic>ORAI1</italic> overexpressing neurons (<xref ref-type="fig" rid="ijms-20-05539-f001">Figure 1</xref>D). The resulting difference in Ca<sup>2+</sup> levels persisted during the subsequent application of ethylene glycol-bis(β-aminoethyl ether)-<italic>N</italic>,<italic>N</italic>,<italic>N</italic>′,<italic>N</italic>′-tetraacetic acid (EGTA) (<xref ref-type="fig" rid="ijms-20-05539-f001">Figure 1</xref>A,C). These changes were absent in neurons with overexpression of <italic>STIM2</italic> (<xref ref-type="fig" rid="ijms-20-05539-f001">Figure 1</xref>E,G). This may suggest that neurons of <italic>ORAI1</italic> transgenic mice exhibit changes in the mechanisms that are responsible for extrusion of Ca<sup>2+</sup> from the cytosol by plasma membrane calcium ATP-ase (PMCA) or Ca<sup>2+</sup> uptake into the ER. Moreover, a tendency towards the increased influx of Ca<sup>2+</sup> ions upon Ca<sup>2+</sup> addback was observed both in <italic>ORAI1</italic> and <italic>STIM2</italic> overexpressing neurons. </p>
</sec>
<sec id="sec2dot2-ijms-20-05539">
<title>2.2. RNAseq Analysis of Transcripts from Hippocampi Indicates Up-Regulation of the Machinery Involved in Ribosome Biogenesis and Ribonucleoprotein Complex Assembly</title>
<p>We next isolated total RNA from hippocampi of wild-type (<italic>n</italic> = 3, age 7 months) and of FVB/NJ-Tg(ORAI1)Ibd (<italic>n</italic> = 3, age 7 months) females and performed RNAseq experiments. Based on the collected RNAseq data, we performed functional (pathways, gene groups) analysis of the genes that were differentially expressed between the hippocampi of wild-type and of FVB/NJ-Tg(Orai1)Ibd females. As shown by the Gene Ontology Biological Process groups (GO BP) (<xref ref-type="fig" rid="ijms-20-05539-f002">Figure 2</xref>A, left), the most down-regulated genes were those belonging to hormone transport group and related with import across plasma membrane and ion transport. Most of the up-regulated genes belonged to the ribonucleprotein complex biogenesis, ribosome biogenesis, and cytoplasmic translation (<xref ref-type="fig" rid="ijms-20-05539-f002">Figure 2</xref>A, right). To extract the complex association between the identified GO BP groups we used the category netplot function (cnetplot). The cnetplot depicts the linkages of genes and biological concepts (GO terms) as a network, which allows to visualize the genes that are involved in the enriched pathways and genes that may belong to multiple annotation categories (<xref ref-type="app" rid="app1-ijms-20-05539">Figure S1</xref>). Among the up-regulated genes, <italic>Orai1</italic> was present, which confirms the identity of transgenic mice (<xref ref-type="fig" rid="ijms-20-05539-f002">Figure 2</xref>C). The lists of genes that were identified among the particular GO BP groups and that are present in dot plots in <xref ref-type="fig" rid="ijms-20-05539-f002">Figure 2</xref>A are listed in data <xref ref-type="app" rid="app1-ijms-20-05539">Supplementary data (Tables S1 and S2)</xref>. The expression of selected genes, some of which are indicated in the volcano plot (<xref ref-type="fig" rid="ijms-20-05539-f002">Figure 2</xref>B), was further validated by the real-time PCR and ddPCR methods. </p>
</sec>
<sec id="sec2dot3-ijms-20-05539">
<title>2.3. Validation of RNAseq Data Using Customized Real-Time PCR Assays and ddPCR Technique Indicates Differential Expression of Dclk1, Cdkl5, and Arx Genes in the Hippocampi of Tg(ORAI1)Ibd Females </title>
<p>We next performed real-time PCR analysis to verify the RNAseq data using customized arrays designed for the 23 genes that are listed in <xref ref-type="table" rid="ijms-20-05539-t001">Table 1</xref>.</p>
<p>As the reference genes, <italic>Uba-2</italic> (catalog no. qMmuCID0018845, Bio-Rad), <italic>Gapdh</italic> (catalog no. qMmuCED0027497, Bio-Rad), and <italic>Actin</italic> (catalog no. qMmuCED0027505, Bio-Rad) were selected, which meet the criteria of the reference gene selection tool (CFX software, Bio-Rad). RNA was isolated from hippocampi of wild-type (<italic>n</italic> = 3, age 5 months) and of FVB/NJ-Tg(ORAI1)Ibd females (<italic>n</italic> = 3, age 6 months). The majority of genes showed a similar level of expression (<xref ref-type="fig" rid="ijms-20-05539-f003">Figure 3</xref>A and <xref ref-type="table" rid="ijms-20-05539-t001">Table 1</xref>) that was calculated as 2<sup>−∆∆Ct</sup>. The genes which were markedly down-regulated in the transgenic individuals included <italic>Arx</italic> (<italic>aristaless related homeobox</italic>) (2<sup>−∆∆Ct</sup> = 0.78, <italic>p</italic> = 0.047), <italic>Dclk1</italic> (<italic>Serine/threonine-protein kinase</italic>) (2<sup>−∆∆Ct</sup> = 0.82, <italic>p</italic> = 0.016), and <italic>Cdkl5 (Cyclin-dependent kinase-like 5)</italic> (2<sup>−∆∆Ct</sup> = 0.85, <italic>p</italic> = 0.02 when only <italic>Actin</italic> was used in the calculations as the reference gene). Human mutations in these genes are associated with epilepsy. Also <italic>Gabrb2</italic> (<italic>Gamma-aminobutyric acid receptor subunit beta-2</italic>) and <italic>Scn9a</italic> (<italic>Sodium channel protein type 9 subunit alpha</italic>) genes, which are implicated in epilepsy, showed altered expression in the transgenic animals (2<sup>−∆∆Ct</sup> = 0.87, <italic>p</italic> = 0.23; 2<sup>−∆∆Ct</sup> = 1.26, <italic>p</italic> = 0.136, respectively). Because the observed changes in 2<sup>−∆∆Ct</sup> values were relatively modest, to validate the changes in expression of the selected genes we used a novel technique, digital droplet PCR (ddPCR, Bio-Rad). This powerful method is based on partitioning of one PCR reaction mixture into up to 20,000 independent reactions, which resulted in high precision, sensitivity, and accuracy of the data [<xref ref-type="bibr" rid="B35-ijms-20-05539">35</xref>]. To fulfill the requirements of validation, the RNA from hippocampi was isolated from the next group of animals (3 wild-type vs. 6 transgenic, age-matched). Using customized assays that were dedicated to ddPCR analysis and <italic>Uba-2</italic> gene as a reference, we observed a reduction in the copy number of <italic>Arx</italic> (43 vs. 69, <italic>p</italic> = 0.0045) in transgenic females. The differences in the copy number of <italic>Cdkl5</italic> and <italic>Dclk1</italic> were insignificant (1470 vs. 1739, <italic>p</italic> = 0.18 and 1501 vs. 1612, <italic>p</italic> = 0.53, respectively). </p>
</sec>
<sec id="sec2dot4-ijms-20-05539">
<title>2.4. Expression of Hes-5, a Transcriptional Repressor That Is Involved in Neurogenesis, Is Up-Regulated in Tg(ORAI1) Ibd Females </title>
<p>In the next set of the real-time PCR analysis based on RNAseq data, we designed an additional 15 pairs of primers (<xref ref-type="table" rid="ijms-20-05539-t002">Table 2</xref>).</p>
<p>Using the matrixes that were derived from previous experiments (6 wild-type vs. 6 transgenic mice) and <italic>Uba-2</italic> as a reference gene<italic>,</italic> we identified an up-regulation of <italic>Hes-5</italic> (Transcription factor <italic>HES-5</italic>) expression (2<sup>−∆∆Ct</sup> = 2,93, <italic>p</italic> = 0.0039) (<xref ref-type="fig" rid="ijms-20-05539-f004">Figure 4</xref>). Among the genes that were analyzed and described in <xref ref-type="table" rid="ijms-20-05539-t002">Table 2</xref>, we detected a trend towards the up-regulation of <italic>Strap</italic> (Serine-threonine kinase receptor-associated protein). The protein is a part of the survival of motor neurons (SMN) complex that acts as a catalyst in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome (2<sup>−∆∆Ct</sup> = 1.56, <italic>p</italic> = 0.18).</p>
</sec>
</sec>
<sec id="sec3-ijms-20-05539" sec-type="discussion">
<title>3. Discussion</title>
<p>The role of SOCE in neurons and its components, such as STIM proteins and Ca<sup>2+</sup> channels, is far from being understood. It becomes clear that not only ORAI and transient receptor potential cation channels (TRPCs) [<xref ref-type="bibr" rid="B36-ijms-20-05539">36</xref>], but also voltage-gated dependent channels (VGCC) [<xref ref-type="bibr" rid="B37-ijms-20-05539">37</xref>] and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors [<xref ref-type="bibr" rid="B38-ijms-20-05539">38</xref>,<xref ref-type="bibr" rid="B39-ijms-20-05539">39</xref>] are sensitive to STIMs. Our group also demonstrated the involvement of STIM1 in mGlur-LTD phenomenon in CA3-CA1 projection of hippocampus in the novel FVB/NJ-Tg(STIM1)Ibd transgenic line [<xref ref-type="bibr" rid="B40-ijms-20-05539">40</xref>]. On the other hand, it is now well established that local Ca<sup>2+</sup> microdomains that appear upon opening of store operated calcium channels activate downstream effectors like calcineurin or adenylyl cyclase in non-excitable cells. The wide scope of processes mediated by Ca<sup>2+</sup> nanodomains that are generated by SOCE is well described in a recent review by Barak and Parekh [<xref ref-type="bibr" rid="B9-ijms-20-05539">9</xref>]. </p>
<p>In hippocampal neurons nSOCE is believed to be mediated mainly by STIM2 together with Orai2 and Trpc6. It was suggested that Ca<sup>2+</sup> that is delivered by nSOCE is responsible for Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) pathway activation, which contributes to spine maintenance of mushroom spines [<xref ref-type="bibr" rid="B41-ijms-20-05539">41</xref>]. Ca<sup>2+</sup> disruption leads to synaptic loss and cognitive decline in aging and Alzheimer’s disease [<xref ref-type="bibr" rid="B41-ijms-20-05539">41</xref>,<xref ref-type="bibr" rid="B42-ijms-20-05539">42</xref>,<xref ref-type="bibr" rid="B43-ijms-20-05539">43</xref>]. The role of nSOCE seems to be even more complex as indicated by the recent results by Chen–Engerer et al. [<xref ref-type="bibr" rid="B26-ijms-20-05539">26</xref>]. They demonstrated that in CA1 pyramidal cells nSOCE that is mediated by ORAI2 is essential for refilling of IP3 sensitive Ca<sup>2+</sup> stores, whereas ryanodine-sensitive stores are VGCC dependent. The authors postulate that their observations may help to explain the distinct roles of inositol triphosphate receptor (IP3Rs) and RyRs for various forms of synaptic plasticity. </p>
<p>As a consequence of <italic>ORAI1</italic> transgene overexpression in mice used in our studies, we modified the level of ORAI1 in neurons, especially in the hippocampus, in which the predominant isoform is ORAI2. The observed trend of a higher amplitude of nSOCE in neurons of Tg(ORAI1)Ibd transgenic mice is in line with the observation by Vaeth et al. (2017), who showed that ORAI2 was a less conductive subunit of CRAC channel in immune cells [<xref ref-type="bibr" rid="B20-ijms-20-05539">20</xref>]. This observation was supported by Fura- 2 quenching experiments using Mn<sup>2+</sup>, in which we observed faster decay of the signal in <italic>ORAI1</italic> overexpressing neurons (<xref ref-type="app" rid="app1-ijms-20-05539">Figure S2</xref>). Because Mn<sup>2+</sup> quenches the fluorescence of Fura-2 and store-operated channels are permeable to them, such approach can be used to assess the activity of SOCs. Moreover, a trend for different kinetics of the [Ca<sup>2+</sup>] decay after glutamate treatment and the subsequent significant differences in the Ca<sup>2+</sup> level in chelating conditions that were described in this work are in agreement with the observations done by Chen–Engerer et al. (2019). They showed the importance of ORAI2-mediated nSOCE in refilling of IP3 sensitive Ca<sup>2+</sup> stores [<xref ref-type="bibr" rid="B26-ijms-20-05539">26</xref>]. Due to the fact that glutamate stimulation also evokes IP3 signaling cascade that in turn leads to Ca<sup>2+</sup> release from the ER, subsequent ORAI-dependent refilling of ER Ca<sup>2+</sup> stores might be altered in neurons of our transgenic line [<xref ref-type="bibr" rid="B44-ijms-20-05539">44</xref>]. These observations suggest that our transgenic line might be a useful tool for an in-depth analysis of specific molecular targets that are activated by nSOCE in the brain. </p>
<p>RNAseq analysis of the material from Tg(ORAI1)Ibd transgenic line identified up-regulation of the genes that belong to the GO biological processes that are involved in the ribonucleoprotein complex biogenesis, ribosome biogenesis, and assembly, which are all components of translational machinery. It was demonstrated in acinar polarized cells that overexpression of STIM1 increased the density of ribosome-free terminals in rough ER (RER), and facilitated the formation of ER-plasma membrane (ER-PM) junctions and SOCE propagation. If our future validation of these RNAseq data by real-time and ddPCR is positive, it may suggest that Ca<sup>2+</sup> microdomains that are generated by nSOCE serve as a regulatory component of the translation process [<xref ref-type="bibr" rid="B45-ijms-20-05539">45</xref>,<xref ref-type="bibr" rid="B46-ijms-20-05539">46</xref>]. </p>
<p>As previously reported by our group, overexpression of ORAI1 in neurons induced seizure-like symptoms in aged female mice [<xref ref-type="bibr" rid="B32-ijms-20-05539">32</xref>]. Application of kainic acid and bicuculline to hippocampal slices from Tg(ORAI1)Ibd females revealed a significantly lower frequency of interictal bursts compared with samples that were isolated from wild-type female or transgenic male mice. The down-regulation of <italic>Arx</italic>, <italic>Cdkl5,</italic> and <italic>Dclk1</italic> genes that we observed in the present work is in line with the report that loss of function mutations of human aristaless related homeobox (<italic>ARX</italic>)<italic>, CDKL5,</italic> and <italic>DCLK1</italic> are found in epileptic patients [<xref ref-type="bibr" rid="B47-ijms-20-05539">47</xref>] (<xref ref-type="table" rid="ijms-20-05539-t003">Table 3</xref>). It might be speculated that the Ca<sup>2+</sup> nanodomains that appear locally by the activity of CRAC channels affect the expression of these genes via downstream pathways.</p>
<p>In conclusion, our data indicate that overexpression of ORAI1 changed the subunit composition of CRAC channels, which caused differences in the observed Ca<sup>2+</sup> responses and induced specific changes in gene expression. By real-time PCR, we detected a down-regulation of <italic>Arx</italic>, <italic>Cdkl5,</italic> and <italic>Dclk1</italic> genes, human homologues of which are involved in etiology of epilepsy. This down-regulation might explain seizure-like phenomena that were observed in 15-month-old females of the FVB/NJ-Tg(ORAI1)Ibd line. </p>
</sec>
<sec id="sec4-ijms-20-05539">
<title>4. Materials and Methods</title>
<sec id="sec4dot1-ijms-20-05539">
<title>4.1. Animal Care</title>
<p>The mice were housed under standard conditions on a 12 h/12 h light/dark cycle with food and water available ad libitum. All of the animal experiments were approved by the Local Commission for the Ethics of Animal Experimentation No. 1 in Warsaw (approval no. 756/2015, 25 May 2015 and approval no. 416/2017, 21 November 2017) and performed in accordance with the European Communities Council Directive (63/2010/EEC, 22 September 2010). All analyses described in the text were performed on 7 ±1-months-old female mice. </p>
</sec>
<sec id="sec4dot2-ijms-20-05539">
<title>4.2. Generation of FVB/NJ–Tg(ORAI1)Ibd Transgenic Mice and Characterization of Transgene Expression</title>
<p>The details on the generation of the transgenic lines were described elsewhere [<xref ref-type="bibr" rid="B32-ijms-20-05539">32</xref>]. In brief, a 1-kb coding sequence of human ORAI1 (cDNA clone MGC:21530 IMAGE:3914595; Dharmacon, USA) was amplified by PCR with XhoI-containing primers (forward 5′-ACTTCACTCGAGACCATGCATCCGGAGCCCG-3′, reverse 5′- ACTTCACTCGAGCTAGGCATAGTGGCTGCCG-3′). The PCR product was digested with <italic>XhoI</italic> and subcloned into the <italic>Xho</italic>I site of the modified mouse Thy-1.2 expression cassette [<xref ref-type="bibr" rid="B66-ijms-20-05539">66</xref>,<xref ref-type="bibr" rid="B67-ijms-20-05539">67</xref>]. The Thy1.2-ORAI1 construct was subsequently digested with <italic>PvuI</italic> and <italic>NotI</italic> and used for typical pronuclear microinjection [<xref ref-type="bibr" rid="B68-ijms-20-05539">68</xref>]. Offspring of the F2 generation and onward were genotyped by PCR using the following primers: Thy_Forw_genotype 5′-TCTGAGTGGCAAAGGACCTTAGG-3′ and ORAI1_Rev_genotype 5′-TGGTCCTGTAAGCGGGCAAAC-3′.</p>
</sec>
<sec id="sec4dot3-ijms-20-05539">
<title>4.3. Brain Slice Preparation</title>
<p>The reagents were purchased from Sigma unless indicated otherwise. Hippocampal sections were prepared according to the protective recovery method [<xref ref-type="bibr" rid="B69-ijms-20-05539">69</xref>]. Mice of the age P25 ± 5 were sacrificed by cervical dislocation. Next, brains were isolated and placed in a dish filled with N-methyl-D-glucamine (NMDG)-based artificial cerebrospinal fluid (NMDG-aCSF) solution that was cooled to ~2°C and contained, in mM: NMDG, 92, KCl, 2.5, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 20, thiourea, 2, glucose, 25, NaH<sub>2</sub>PO<sub>4</sub>, 1.25, NaHCO<sub>3</sub>, 30, MgSO<sub>4</sub>, 10, CaCl<sub>2</sub>, 0.5, Na-ascorbate, 5, Na-pyruvate, 3 N-acetyl-L-cystein (NAC, myprotein.com, Manchester, United Kingdom), 3. Sections that were 350 μm thick were obtained with the use of a vibratome (HM 650V, Thermo Scientific, Waltham, MA, USA). During the slicing procedure, the tissue was submerged in ice-cold NMDG-aCSF solution that was bubbled with carbogen (95%/5% O<sub>2</sub>/CO<sub>2</sub>). Next, the sections were incubated in carbogenated NMDG aCSF for 10 min (temperature: ~33 °C). A 2M NaCl solution was gradually added to the solution according to [<xref ref-type="bibr" rid="B69-ijms-20-05539">69</xref>]. The slices were then transferred to HEPES-based aCSF that contained, in mM: NaCl, 82, KCl, 2.5, HEPES, 20, thiourea, 2, glucose, 25, NaH<sub>2</sub>PO<sub>4</sub>, 1.25, NaHCO<sub>3</sub>, 30, MgSO<sub>4</sub>, 2, Na-ascorbate, 5, Na-pyruvate, 3, and 12 mM NAC (temperature: ~25 °C). The recordings were started after 1 h of incubation in HEPES-aCSF. The pH of all of the solutions was between 7.3 and 7.4. </p>
</sec>
<sec id="sec4dot4-ijms-20-05539">
<title>4.4. Dye-Loading Procedure</title>
<p>A 1 mM stock of Fura-2 AM (Thermo-Fisher) that was dissolved in DMSO was diluted in artificial cerebrospinal fluid (aCSF) (it contained, in mM: NaCl, 126, KCl, 2.2, glucose, 20, NaH<sub>2</sub>PO<sub>4</sub>, 1.25, NaHCO<sub>3</sub>, 25, MgSO<sub>4</sub>, 1, and CaCl<sub>2</sub>, 2.5; the pH was adjusted to 7.3–7.4) to a final concentration of 50 µM. The solution was supplemented with Pluronic F-127 (Sigma-Aldrich, St. Louis, MO, USA) at a final concentration of 2.5%. The dye solution was applied locally above the hippocampal slice with the use of Perfusion Pencil (Automate Scientific, Berkeley, CA, USA), for 20 min. During the loading procedure, the slices were perfused with aCSF solution at a rate of 4–5 mL/min, at 33 °C, to facilitate incorporation of the dye molecules by the cells. After the loading, the slices were allowed to rest for 20 min, under a constant perfusion of aCSF at a temperature of 25 °C. The consistency of the loading procedure was checked by acquiring fluorescent Fura-2 signal at its isosbestic point (λ = 360 nm). The intensity of the signal excited at this wavelength should not depend on Ca<sup>2+</sup> concentration and thus only reflect the quantity of the incorporated and de-esterified dye alone. The signal was comparable across preparations. Moreover, we did not detect any correlation between the loading efficiency and the magnitude of the recorded Ca<sup>2+</sup> responses.</p>
</sec>
<sec id="sec4dot5-ijms-20-05539">
<title>4.5. Ca<sup>2+</sup> Imaging of Neurons in Brain Slices</title>
<p>The measurements were performed using MetaFluor software, a Zeiss Examiner Z.1 microscope (40×/1.0 objective), and the Retiga ELECTRO™ CCD Camera (Teledyne Qimaging, Surrey, BC, Canada). A peristaltic pump was used to perfuse the hippocampal slices with aCSF that contained 126 mM NaCl, 2.6 mM KCl, 20 mM glucose, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 25 mM NaHCO<sub>3,</sub> and 1 mM MgSO<sub>4</sub>. Additionally, aCSF that contained chemicals used for evoking Ca<sup>2+</sup> responses was applied locally through a 100 µm wide tip that was positioned 100 µm above the pyramidal neurons of the CA1 hippocampal area. The pencil was connected to an automated perfusion system ValveLink 8.2 (Automate Scientific, Berkeley, CA, USA). For the first 10 min of the recordings (baseline recording, glutamate application, and signal relaxation), 2.5 mM CaCl<sub>2</sub> was included in the solution that was perfused with the use of the pump. Next, the solution was manually changed to Ca<sup>2+</sup>-free aCSF that contained 0.5 mM (ethylene glycol-bis(β-aminoethyl ether)-<italic>N</italic>,<italic>N</italic>,<italic>N</italic>′,<italic>N</italic>′-tetraacetic acid) EGTA. The pH of aCSF was adjusted to 7.4 at room temperature with carbogen and HCl. The extracellular solution was carbogenated throughout the recordings and heated with an in-line heater (catalog no. 64-0102, controlled by a TC-324B temperature control unit, Warner Instruments) to maintain the temperature in the recording chamber close to 25 °C. The rate of solution flow was 4–5 mL/min.</p>
<p>To assess Ca<sup>2+</sup> homeostasis in the CA1 pyramidal neurons of the hippocampus, a Ca<sup>2+</sup> addback assay that was modified to allow for the quantification of the Ca<sup>2+</sup> efflux from the ER [<xref ref-type="bibr" rid="B33-ijms-20-05539">33</xref>] was used. Changes in the fluorescent signal in the neuronal cell bodies were monitored and quantified. For baseline recording, aCSF that contained 2.5 mM Ca<sup>2+</sup> was perfused for 5 min, which was followed by the local application of 100 µM Na-glutamate for 10s. Next, the signal relaxation was monitored for another 5 min in 2.5 mM Ca<sup>2+</sup> aCSF. To deplete the extracellular milieu from the Ca<sup>2+</sup> ions, the solution was changed to aCSF that contained 0.5 mM EGTA for 15 min, which was followed by the local application of 20 μM cyclopiazonic acid (CPA) for 5 min. Next, Ca<sup>2+</sup> was re-added to the solution at a concentration of 5 mM Ca<sup>2+</sup> for 5 min, in the presence of 20 μM CPA. To limit activity-driven Ca<sup>2+</sup> entry, 1 μM Tetrodotoxin (TTX) and 10 μM nifedipine were included in all solutions that were used from the 10th min of the experiment onwards. </p>
<p>For Fura-2 quenching experiments, hippocampal slices were loaded with the dye as described above. For baseline recording, Ringer’s solution (composed of, in mM: NaCl, 137, KCl, 5, glucose, 24, HEPES, 10, CaCl<sub>2</sub>, 2, MgCl<sub>2</sub>, 1, pH = 7.3–7.4) was perfused for 5 min, which was followed by application of Ca<sup>2+</sup>-free Ca<sup>2+</sup> depleting solution (Ringer’s solution supplemented with 0.5 mM EGTA and 20 μM CPA) for 15 min. Next, Ca<sup>2+</sup>-free Ringer’s solution supplemented with 2 mM Mn<sup>2+</sup> (as MnCl<sub>2</sub>) was locally applied above the cells of interest, in the absence of EGTA and presence of 20 μM CPA. To limit activity-driven Ca<sup>2+</sup> entry, 1 μM TTX and 10 μM nifedipine were included in all solutions. To quantify the rate of Mn<sup>2+</sup> influx, linear part of the curves following Mn<sup>2+</sup> addition (which corresponded to the first 25 s of treatment) were approximated with a linear function and the decay slope was calculated (all calculations performed in Microsoft Excel).</p>
</sec>
<sec id="sec4dot6-ijms-20-05539">
<title>4.6. Data Analysis </title>
<p>The acquired signals were quantified and exported with the use of MetaFluor software and further analyzed with Microsoft Excel and GraphPad Prism 5 (USA). Student’s <italic>t</italic>-test was used to check the statistical significance of the observed differences between the groups.</p>
</sec>
<sec id="sec4dot7-ijms-20-05539">
<title>4.7. Global Gene Expression Profiling</title>
<p>Total RNA was extracted from three individual hippocampi per variant using RNeasy Lipid Mini Kit (Qiagen: 74804, Hilden, Germany) and treated on-column with DNase using the RNase-Free DNase Set (Qiagen: 79254). Preparation of cDNA libraries and sequencing by Illumina HighSeq 1500 (run type: Paired-end sequencing, read length: 1 × 76 bp) were carried out in cooperation with Core Facility of IIMCB and the Nencki Institute. Sequencing reads (fastq) were filtered by Trimmomatic program, discarding all reads contaminated by sequencing adapter sequence as well as discarding reads whose mean quality in a bin of 20 base pair (bp) was below Q30. Minimal length of read used for mapping was set as 65 bp. Quality filtered reads were aligned to mouse genome (mm10) by STAR program. Statistical analyses, including comparisons to other samples, were done in R environment using NOIseq library [<xref ref-type="bibr" rid="B70-ijms-20-05539">70</xref>]. Functional analysis was performed for the genes that were differentially expressed in transgenic versus wild-type samples (raw <italic>p</italic>-value below 0.05), separately for genes up- and down-regulated in transgenic animals. The functional analysis of data was performed using clusterProfiler [<xref ref-type="bibr" rid="B71-ijms-20-05539">71</xref>] to find statistically significant Gene Ontology terms. The whole metadata of RNAseq analysis deposit in NCBI’s Gene Expression Omnibus [<xref ref-type="bibr" rid="B72-ijms-20-05539">72</xref>] and are accessible through GEO Series accession number GSE138370 (<uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138370">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138370</uri>).</p>
</sec>
<sec id="sec4dot8-ijms-20-05539">
<title>4.8. Real-Time Polymerase Chain Reaction Arrays and Quantitative Real-Time PCR (qPCR)</title>
<p>Hippocampi were dissected from three adult female mice (≥ postnatal day 180 (PD180)) per variant for real-time polymerase chain reaction arrays. The material was homogenized in Qiazol (Qiagen, catalog no. 79306, Germany) and subjected to total RNA isolation according to manufacturer’s protocol of RNeasy Lipid Tissue Mini Kit (Qiagen: 74804, Germany). The quality of RNA was checked by absorbance measurements at 260, 280, and 230 nm. For the analysis, only samples whose A260/280 nm and A230/280 nm values exceeded 1.8 were used. There were 1000 ng of RNA templates used to synthesize first-strand cDNA, with the use of iScript reverse transcription supermix (Bio-Rad: 170–8841, USA). The 96-well custom plates that contained primers for target and reference genes (Bio-Rad, USA) and SsoAdvanced Universal SYBR Green Supermix (Bio-Rad:1725274; USA) were used to perform teal-time polymerase chain reaction (RT-PCR, carried out in duplicate). The cDNA (50 ng) was used for each reaction. Small Ubiquitin-like Modifier (SUMO)-activating enzyme subunit 2 (<italic>Uba-2)</italic>, glyceraldehyde-3-phosphate dehydrogenase (<italic>Gapdh</italic>), and <italic>Actin (Actb)</italic> were used as reference genes. The reactions were performed using the CFX Connect™ Real-Time PCR Detection System (Bio-Rad). Bio-Rad CFX Maestro 1.1 software was used to analyze the data (Bio-Rad, USA). The reference genes’ stability was acceptable (as evaluated by the reference gene selection tool). For calculation of the expression levels, equal efficiencies were assumed for all reactions and the 2<sup>−∆∆Ct</sup> method was used. For each gene, the average normalized expression was calculated from the following formula:<disp-formula id="FD1-ijms-20-05539"><mml:math id="mm1"><mml:mrow><mml:mrow><mml:mrow><mml:mi>Normalized</mml:mi><mml:mo> </mml:mo><mml:mi>expressionGOI</mml:mi><mml:mo> </mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>R</mml:mi><mml:mi>Q</mml:mi><mml:mi>GOI</mml:mi><mml:mo>/</mml:mo><mml:msup><mml:mrow><mml:mfenced><mml:mrow><mml:mi>R</mml:mi><mml:mi>Q</mml:mi><mml:mi>U</mml:mi><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>R</mml:mi><mml:mi>Q</mml:mi><mml:mi>G</mml:mi><mml:mi>a</mml:mi><mml:mi>p</mml:mi><mml:mi>d</mml:mi><mml:mi>h</mml:mi><mml:mo>×</mml:mo><mml:mi>R</mml:mi><mml:mi>Q</mml:mi><mml:mi>A</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mn>3</mml:mn></mml:mfrac></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></disp-formula>
where: GOI, gene of interest; RQ, relative quantity, calculated as RQ = 2<sup>(−CtGOI)</sup>.</p>
<p>The statistical significance of the observed differences in the expression levels between the tested groups was determined with the use of analysis of variance (ANOVA), followed by Tukey’s Honestly Significant Difference (HSD) post-hoc test.</p>
<p>The real-time PCR reactions were performed in duplicate for each sample using SsoAdvance Universal SYBR Green Supermix (Bio-Rad) with the following sets of specific gene primers (the primer sequences are listed in <xref ref-type="table" rid="ijms-20-05539-t002">Table 2</xref>, Sigma). Based on the real-time PCR arrays, <italic>SUMO-activating enzyme subunit 2</italic> (<italic>Uba-2)</italic> was chosen as reference gene. The specificity of the reactions was determined based on dissociation curve analysis. Relative gene expression was calculated using the 2<sup>−ΔΔCt</sup> method and Bio-Rad CFX Maestro 1.1 software (Bio-Rad, USA). Six adult female mice (≥ postnatal day 180 (PD180), per variant were taken to perform this experiment.</p>
</sec>
<sec id="sec4dot9-ijms-20-05539">
<title>4.9. DdPCR Validation of Selected Genes</title>
<p>Primers for <italic>Arx</italic>, <italic>Cdkl5</italic>, <italic>Dclk1</italic>, and <italic>Uba2</italic> were sourced from the EvaGreen ddPCR™ assays (Bio-Rad: dMmuEG5062557; dMmuEG5078166; dMmuEG5084027; dMmuEG5081512, respectively) and diluted according to the kit instructions. For ddPCR technology (QX200 Droplet Digital PCR ddPCR™) System—Bio-Rad, USA) 21 μL reaction mixtures containing 25 ng of cDNA (six transgenics mice vs. 3 wild-type mice variant), primers, and QX200™ddPCR™ EvaGreen Supermix (Bio-Rad: 186–4034) were used. Droplet generation and transfer of emulsified samples to PCR plates (Bio-Rad: 12001925) were performed according to the manufacturer’s instructions (Instruction Manual, QX200™ Droplet Generator—Bio-Rad). The ddPCR plate was sealed with a foil heat seal (Bio-Rad, 181–4040) and the PX1™ PCR Plate Sealer (Bio-Rad; 181–4000). The following cycling protocol was established according to the manufacturer’s protocol: 95 °C enzyme activation step for 5 min followed by 40 cycles of a two-step cycling protocol (95 °C for 30 s and 58 °C for 1 min). The ramp rate between these steps was slowed to 2 °C/second. The post-cycling protocol was in accordance with the kit instructions (Bio-Rad, 186–4034). The absolute quantity of DNA per sample (copies/μL) was processed using QuantaSoft version 1.7.4.0917 (Bio-Rad, USA). The data were next exported to Microsoft Excel for further analysis. </p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank T. Węgierski for his critical comments regarding the manuscript and A. Maciąg for his support in calculations.</p>
</ack>
<app-group>
<app id="app1-ijms-20-05539">
<title>Supplementary Materials</title>
<p>The following are available online at <uri xlink:href="https://www.mdpi.com/1422-0067/20/22/5539/s1">https://www.mdpi.com/1422-0067/20/22/5539/s1</uri>.</p>
<supplementary-material content-type="local-data" id="ijms-20-05539-s001">
<media xlink:href="ijms-20-05539-s001.zip">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</app>
</app-group>
<notes>
<title>Author Contributions</title>
<p>L.M. and J.K. designed research. L.M., B.W., and F.M. conducted the experiments and analyzed the data. L.M. and J.K. wrote the manuscript, with input from F.M. and B.W.</p>
</notes>
<notes>
<title>Funding</title>
<p>This research was funded by Commercialization Quest internal Grant Program of IIMCB no. QC_4 LM and MAESTRO grant to J.K. from a National Science Centre (2011/02/A/NZ3/00144).</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</p>
</notes>
<glossary>
<title>Abbreviations</title>
<array orientation="portrait">
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">a.u.</td>
<td align="left" colspan="1" rowspan="1" valign="middle">arbitrary units</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">aCSF</td>
<td align="left" colspan="1" rowspan="1" valign="middle">artificial cerebrospinal fluid</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">AM</td>
<td align="left" colspan="1" rowspan="1" valign="middle">acetomethyl ester</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">AMPA</td>
<td align="left" colspan="1" rowspan="1" valign="middle">α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Arx</td>
<td align="left" colspan="1" rowspan="1" valign="middle">aristaless related homeobox</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">CaMKII</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Ca<sup>2+</sup>/calmodulin-dependent protein kinase II</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Cdkl5</td>
<td align="left" colspan="1" rowspan="1" valign="middle">cyclin-dependent kinase-like 5, also known as serine/threonine kinase 9 (STK9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">CPA</td>
<td align="left" colspan="1" rowspan="1" valign="middle">cyclopiazonic acid</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">CRAC</td>
<td align="left" colspan="1" rowspan="1" valign="middle">calcium release activated channel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">EGTA</td>
<td align="left" colspan="1" rowspan="1" valign="middle">ethylene glycol-bis(β-aminoethyl ether)-<italic>N</italic>,<italic>N</italic>,<italic>N</italic>′,<italic>N</italic>′-tetraacetic acid</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Dclk1</td>
<td align="left" colspan="1" rowspan="1" valign="middle">doublecortin like kinase 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ddPCR</td>
<td align="left" colspan="1" rowspan="1" valign="middle">digital droplet PCR</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">DRG</td>
<td align="left" colspan="1" rowspan="1" valign="middle">dorsal root ganglion</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ER</td>
<td align="left" colspan="1" rowspan="1" valign="middle">endoplasmic reticulum</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">FPKM</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Fragments Per Kilobase Million</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Fura-2 AM</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Fura-2 acetomethyl ester</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">GO BP</td>
<td align="left" colspan="1" rowspan="1" valign="middle">gene ontology biological process</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Hes-5</td>
<td align="left" colspan="1" rowspan="1" valign="middle">hairy and enhancer of split-5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Ibd</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Institute of Experimental Biology, in Polish: Instytut Biologii Doświadczalnej</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">IP3R</td>
<td align="left" colspan="1" rowspan="1" valign="middle">inositol triphosphate receptor</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NMDG</td>
<td align="left" colspan="1" rowspan="1" valign="middle">N-methyl-D-glucamine</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">nSOCE</td>
<td align="left" colspan="1" rowspan="1" valign="middle">neuronal store operated calcium entry</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">PMCA</td>
<td align="left" colspan="1" rowspan="1" valign="middle">plasma membrane calcium ATP-ase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">RER</td>
<td align="left" colspan="1" rowspan="1" valign="middle">rough endoplasmic reticulum</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">RNASeq</td>
<td align="left" colspan="1" rowspan="1" valign="middle">RNA sequencing</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SOCE</td>
<td align="left" colspan="1" rowspan="1" valign="middle">store operated calcium entry</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">STIM</td>
<td align="left" colspan="1" rowspan="1" valign="middle">stromal interaction molecule</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Tg</td>
<td align="left" colspan="1" rowspan="1" valign="middle">transgenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">TRPCs</td>
<td align="left" colspan="1" rowspan="1" valign="middle">transient receptor potential cation channels</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">TTX</td>
<td align="left" colspan="1" rowspan="1" valign="middle">tetrodotoxin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">VGCC</td>
<td align="left" colspan="1" rowspan="1" valign="middle">voltage-gated calcium channel</td>
</tr>
</tbody>
</array>
</glossary>
<ref-list>
<title>References</title>
<ref id="B1-ijms-20-05539">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Putney</surname>
<given-names>J.W.</given-names>
<suffix>Jr.</suffix>
</name>
</person-group>
<article-title>A model for receptor-regulated calcium entry</article-title>
<source/>Cell Calcium
          <year>1986</year>
<volume>7</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/0143-4160(86)90026-6</pub-id>
<pub-id pub-id-type="pmid">2420465</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-20-05539">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majewski</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kuznicki</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>SOCE in neurons: Signaling or just refilling?</article-title>
<source/>Biochim. Biophys. Acta
          <year>2015</year>
<volume>1853</volume>
<fpage>1940</fpage>
<lpage>1952</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamcr.2015.01.019</pub-id>
<pub-id pub-id-type="pmid">25646572</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-20-05539">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moccia</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zuccolo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Soda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tanzi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guerra</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mapelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lodola</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>D’Angelo</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Stim and Orai proteins in neuronal Ca(2+) signaling and excitability</article-title>
<source/>Front. Cell. Neurosci.
          <year>2015</year>
<volume>9</volume>
<fpage>153</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00153</pub-id>
<pub-id pub-id-type="pmid">25964739</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-20-05539">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fivaz</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Neuronal SOCE: Myth or Reality?</article-title>
<source/>Trends Cell Biol.
          <year>2016</year>
<volume>26</volume>
<fpage>890</fpage>
<lpage>893</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2016.09.008</pub-id>
<pub-id pub-id-type="pmid">27720332</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-20-05539">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wegierski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kuznicki</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Neuronal calcium signaling via store-operated channels in health and disease</article-title>
<source/>Cell Calcium
          <year>2018</year>
<volume>74</volume>
<fpage>102</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1016/j.ceca.2018.07.001</pub-id>
<pub-id pub-id-type="pmid">30015245</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-20-05539">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poggioli</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mauger</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Guesdon</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Claret</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>A regulatory calcium-binding site for calcium channel in isolated rat hepatocytes</article-title>
<source/>J. Biol. Chem.
          <year>1985</year>
<volume>260</volume>
<fpage>3289</fpage>
<lpage>3294</lpage>
<pub-id pub-id-type="pmid">2579075</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-20-05539">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Cahalan</surname>
<given-names>M.D.</given-names>
</name>
</person-group>
<article-title>Mitogen-induced oscillations of cytosolic Ca<sup>2+</sup> and transmembrane Ca<sup>2+</sup> current in human leukemic T cells</article-title>
<source/>Cell Regul.
          <year>1989</year>
<volume>1</volume>
<fpage>99</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1091/mbc.1.1.99</pub-id>
<pub-id pub-id-type="pmid">2519622</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-20-05539">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penner</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Neher</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Regulation of calcium influx by second messengers in rat mast cells</article-title>
<source/>Nature
          <year>1988</year>
<volume>334</volume>
<fpage>499</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="doi">10.1038/334499a0</pub-id>
<pub-id pub-id-type="pmid">2457169</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-20-05539">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barak</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Parekh</surname>
<given-names>A.B.</given-names>
</name>
</person-group>
<article-title>Signaling through Ca(2+) Microdomains from Store-Operated CRAC Channels</article-title>
<source/>Cold Spring Harb. Perspect. Biol.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1101/cshperspect.a035097</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-20-05539">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bird</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Putney</surname>
<given-names>J.W.</given-names>
<suffix>Jr.</suffix>
</name>
</person-group>
<article-title>Capacitative calcium entry supports calcium oscillations in human embryonic kidney cells</article-title>
<source/>J. Physiol.
          <year>2005</year>
<volume>562</volume>
<fpage>697</fpage>
<lpage>706</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2004.077289</pub-id>
<pub-id pub-id-type="pmid">15513935</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-20-05539">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cuk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ouimet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hornig-Do</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>Chrzanowska-Lightowlers</surname>
<given-names>Z.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Store-Operated Ca(2+) Entry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism</article-title>
<source/>Cell Metab.
          <year>2017</year>
<volume>25</volume>
<fpage>698</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2016.12.021</pub-id>
<pub-id pub-id-type="pmid">28132808</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-20-05539">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lacruz</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Feske</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Diseases caused by mutations in ORAI1 and STIM1</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2015</year>
<volume>1356</volume>
<fpage>45</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1111/nyas.12938</pub-id>
<pub-id pub-id-type="pmid">26469693</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-20-05539">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Heo</surname>
<given-names>W.D.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Ferrell</surname>
<given-names>J.E.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Meyer</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>STIM is a Ca<sup>2+</sup> sensor essential for Ca<sup>2+</sup>-store-depletion-triggered Ca<sup>2+</sup> influx</article-title>
<source/>Curr. Biol.
          <year>2005</year>
<volume>15</volume>
<fpage>1235</fpage>
<lpage>1241</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2005.05.055</pub-id>
<pub-id pub-id-type="pmid">16005298</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-20-05539">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roos</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Di Gregorio</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Yeromin</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Ohlsen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lioudyno</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Safrina</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kozak</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Cahalan</surname>
<given-names>M.D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>STIM1, an essential and conserved component of store-operated Ca<sup>2+</sup> channel function</article-title>
<source/>J. Cell Biol.
          <year>2005</year>
<volume>169</volume>
<fpage>435</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200502019</pub-id>
<pub-id pub-id-type="pmid">15866891</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-20-05539">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feske</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gwack</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Prakriya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Srikanth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Puppel</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Tanasa</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function</article-title>
<source/>Nature
          <year>2006</year>
<volume>441</volume>
<fpage>179</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.1038/nature04702</pub-id>
<pub-id pub-id-type="pmid">16582901</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-20-05539">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vig</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peinelt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koomoa</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Rabah</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Koblan-Huberson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kraft</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fleig</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Penner</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CRACM1 is a plasma membrane protein essential for store-operated Ca<sup>2+</sup> entry</article-title>
<source/>Science
          <year>2006</year>
<volume>312</volume>
<fpage>1220</fpage>
<lpage>1223</lpage>
<pub-id pub-id-type="doi">10.1126/science.1127883</pub-id>
<pub-id pub-id-type="pmid">16645049</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-20-05539">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prakriya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Feske</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gwack</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Srikanth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>P.G.</given-names>
</name>
</person-group>
<article-title>Orai1 is an essential pore subunit of the CRAC channel</article-title>
<source/>Nature
          <year>2006</year>
<volume>443</volume>
<fpage>230</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1038/nature05122</pub-id>
<pub-id pub-id-type="pmid">16921383</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-20-05539">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Pedi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Diver</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>S.B.</given-names>
</name>
</person-group>
<article-title>Crystal structure of the calcium release-activated calcium channel Orai</article-title>
<source/>Science
          <year>2012</year>
<volume>338</volume>
<fpage>1308</fpage>
<lpage>1313</lpage>
<pub-id pub-id-type="doi">10.1126/science.1228757</pub-id>
<pub-id pub-id-type="pmid">23180775</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-20-05539">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lokteva</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Functional Analysis of Orai1 Concatemers Supports a Hexameric Stoichiometry for the CRAC Channel</article-title>
<source/>Biophys. J.
          <year>2016</year>
<volume>111</volume>
<fpage>1897</fpage>
<lpage>1907</lpage>
<pub-id pub-id-type="doi">10.1016/j.bpj.2016.09.020</pub-id>
<pub-id pub-id-type="pmid">27806271</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-20-05539">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaeth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zee</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Eckstein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Knosp</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Karoly Jani</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lacruz</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Flockerzi</surname>
<given-names>V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ORAI2 modulates store-operated calcium entry and T cell-mediated immunity</article-title>
<source/>Nat. Commun.
          <year>2017</year>
<volume>8</volume>
<fpage>14714</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms14714</pub-id>
<pub-id pub-id-type="pmid">28294127</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-20-05539">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsvilovskyy</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Solis-Lopez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Medert</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Roers</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kriebs</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Freichel</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Deletion of Orai2 augments endogenous CRAC currents and degranulation in mast cells leading to enhanced anaphylaxis</article-title>
<source/>Cell Calcium
          <year>2018</year>
<volume>71</volume>
<fpage>24</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1016/j.ceca.2017.11.004</pub-id>
<pub-id pub-id-type="pmid">29604961</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-20-05539">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckstein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vaeth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aulestia</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Costiniti</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kassam</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Bromage</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Issekutz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Idaghdour</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Moursi</surname>
<given-names>A.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differential regulation of Ca(2+) influx by ORAI channels mediates enamel mineralization</article-title>
<source/>Sci. Signal.
          <year>2019</year>
<volume>12</volume>
<fpage>eaav4663</fpage>
<pub-id pub-id-type="doi">10.1126/scisignal.aav4663</pub-id>
<pub-id pub-id-type="pmid">31015290</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-20-05539">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Orai1 and Orai3 Mediate Store-Operated Calcium Entry Contributing to Neuronal Excitability in Dorsal Root Ganglion Neurons</article-title>
<source/>Front. Cell. Neurosci.
          <year>2017</year>
<volume>11</volume>
<fpage>400</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2017.00400</pub-id>
<pub-id pub-id-type="pmid">29311831</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-20-05539">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schindl</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Frischauf</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bergsmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Muik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Derler</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lackner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Groschner</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Romanin</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Plasticity in Ca<sup>2+</sup> selectivity of Orai1/Orai3 heteromeric channel</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>19623</fpage>
<lpage>19628</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0907714106</pub-id>
<pub-id pub-id-type="pmid">19887627</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-20-05539">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feske</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Skolnik</surname>
<given-names>E.Y.</given-names>
</name>
<name>
<surname>Prakriya</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Ion channels and transporters in lymphocyte function and immunity</article-title>
<source/>Nat. Rev. Immunol.
          <year>2012</year>
<volume>12</volume>
<fpage>532</fpage>
<lpage>547</lpage>
<pub-id pub-id-type="doi">10.1038/nri3233</pub-id>
<pub-id pub-id-type="pmid">22699833</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-20-05539">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen-Engerer</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Karl</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feske</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Konnerth</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Two types of functionally distinct Ca(2+) stores in hippocampal neurons</article-title>
<source/>Nat. Commun.
          <year>2019</year>
<volume>10</volume>
<fpage>3223</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-019-11207-8</pub-id>
<pub-id pub-id-type="pmid">31324793</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-20-05539">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vashisht</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tanwar</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Motiani</surname>
<given-names>R.K.</given-names>
</name>
</person-group>
<article-title>Regulation of proto-oncogene Orai3 by miR18a/b and miR34a</article-title>
<source/>Cell Calcium
          <year>2018</year>
<volume>75</volume>
<fpage>101</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1016/j.ceca.2018.08.006</pub-id>
<pub-id pub-id-type="pmid">30216788</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-20-05539">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Niemeyer</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>The neglected CRAC proteins: Orai2, Orai3, and STIM2</article-title>
<source/>Curr. Top. Membr.
          <year>2013</year>
<volume>71</volume>
<fpage>237</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="pmid">23890118</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-20-05539">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prakriya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Store-Operated Calcium Channels</article-title>
<source/>Physiol. Rev.
          <year>2015</year>
<volume>95</volume>
<fpage>1383</fpage>
<lpage>1436</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00020.2014</pub-id>
<pub-id pub-id-type="pmid">26400989</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-20-05539">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaeth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Feske</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Ion channelopathies of the immune system</article-title>
<source/>Curr. Opin. Immunol.
          <year>2018</year>
<volume>52</volume>
<fpage>39</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/j.coi.2018.03.021</pub-id>
<pub-id pub-id-type="pmid">29635109</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-20-05539">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feske</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>CRAC channels and disease—From human CRAC channelopathies and animal models to novel drugs</article-title>
<source/>Cell Calcium
          <year>2019</year>
<volume>80</volume>
<fpage>112</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.ceca.2019.03.004</pub-id>
<pub-id pub-id-type="pmid">31009822</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-20-05539">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maciag</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Majewski</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Boguszewski</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Wasilewska</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Wojtas</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kuznicki</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Behavioral and electrophysiological changes in female mice overexpressing ORAI1 in neurons</article-title>
<source/>Biochim. Biophys. Acta Mol. Cell Res.
          <year>2019</year>
<volume>1866</volume>
<fpage>1137</fpage>
<lpage>1150</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamcr.2019.01.007</pub-id>
<pub-id pub-id-type="pmid">30659848</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-20-05539">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kipanyula</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Contreras</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zampese</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lazzari</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Pizzo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fasolato</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pozzan</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Ca<sup>2+</sup> dysregulation in neurons from transgenic mice expressing mutant presenilin 2</article-title>
<source/>Aging Cell
          <year>2012</year>
<volume>11</volume>
<fpage>885</fpage>
<lpage>893</lpage>
<pub-id pub-id-type="doi">10.1111/j.1474-9726.2012.00858.x</pub-id>
<pub-id pub-id-type="pmid">22805202</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-20-05539">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amrhein</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Greenland</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McShane</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Scientists rise up against statistical significance</article-title>
<source/>Nature
          <year>2019</year>
<volume>567</volume>
<fpage>305</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="doi">10.1038/d41586-019-00857-9</pub-id>
<pub-id pub-id-type="pmid">30894741</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-20-05539">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Laperriere</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Germain</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: From variable nonsense to publication quality data</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>2409</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-02217-x</pub-id>
<pub-id pub-id-type="pmid">28546538</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-20-05539">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Karl</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Adelsberger</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Brill</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Ruhlmann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ansel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sakimura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Baba</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kurosaki</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>STIM1 controls neuronal Ca(2+) signaling, mGluR1-dependent synaptic transmission, and cerebellar motor behavior</article-title>
<source/>Neuron
          <year>2014</year>
<volume>82</volume>
<fpage>635</fpage>
<lpage>644</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.03.027</pub-id>
<pub-id pub-id-type="pmid">24811382</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-20-05539">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dittmer</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Wild</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Dell’Acqua</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Sather</surname>
<given-names>W.A.</given-names>
</name>
</person-group>
<article-title>STIM1 Ca(2+) Sensor Control of L-type Ca(2+)-Channel-Dependent Dendritic Spine Structural Plasticity and Nuclear Signaling</article-title>
<source/>Cell Rep.
          <year>2017</year>
<volume>19</volume>
<fpage>321</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.03.056</pub-id>
<pub-id pub-id-type="pmid">28402855</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-20-05539">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Alvarez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yap</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Thevathasan</surname>
<given-names>J.V.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Mancuso</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>STIM2 regulates PKA-dependent phosphorylation and trafficking of AMPARs</article-title>
<source/>Mol. Biol. Cell
          <year>2015</year>
<volume>26</volume>
<fpage>1141</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="doi">10.1091/mbc.E14-07-1222</pub-id>
<pub-id pub-id-type="pmid">25609091</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-20-05539">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gruszczynska-Biegala</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sladowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuznicki</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>AMPA Receptors Are Involved in Store-Operated Calcium Entry and Interact with STIM Proteins in Rat Primary Cortical Neurons</article-title>
<source/>Front. Cell. Neurosci.
          <year>2016</year>
<volume>10</volume>
<fpage>251</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2016.00251</pub-id>
<pub-id pub-id-type="pmid">27826230</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-20-05539">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majewski</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Maciag</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Boguszewski</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Wasilewska</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Wiera</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wojtowicz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mozrzymas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kuznicki</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Overexpression of STIM1 in neurons in mouse brain improves contextual learning and impairs long-term depression</article-title>
<source/>Biochim. Biophys. Acta Mol. Cell Res.
          <year>2017</year>
<volume>1864</volume>
<fpage>1071</fpage>
<lpage>1087</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamcr.2016.11.025</pub-id>
<pub-id pub-id-type="pmid">27913207</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-20-05539">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Popugaeva</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Feske</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>C.L.</given-names>
<suffix>III</suffix>
</name>
<name>
<surname>Bezprozvanny</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Reduced synaptic STIM2 expression and impaired store-operated calcium entry cause destabilization of mature spines in mutant presenilin mice</article-title>
<source/>Neuron
          <year>2014</year>
<volume>82</volume>
<fpage>79</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.02.019</pub-id>
<pub-id pub-id-type="pmid">24698269</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-20-05539">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pchitskaya</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zakharova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Fon Tacer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bezprozvanny</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer’s Disease Treatment</article-title>
<source/>J. Neurosci.
          <year>2016</year>
<volume>36</volume>
<fpage>11837</fpage>
<lpage>11850</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1188-16.2016</pub-id>
<pub-id pub-id-type="pmid">27881772</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-20-05539">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wojda</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Kuznicki</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease modeling: Ups, downs, and perspectives for human induced pluripotent stem cells</article-title>
<source/>J. Alzheimer Dis.
          <year>2013</year>
<volume>34</volume>
<fpage>563</fpage>
<lpage>588</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-121984</pub-id>
<pub-id pub-id-type="pmid">23313930</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-20-05539">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greget</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pernot</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bouteiller</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Ghaderi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Allam</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Ambert</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Legendre</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sarmis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haeberle</surname>
<given-names>O.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Simulation of postsynaptic glutamate receptors reveals critical features of glutamatergic transmission</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<elocation-id>e28380</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0028380</pub-id>
<pub-id pub-id-type="pmid">22194830</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-20-05539">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiler</surname>
<given-names>I.J.</given-names>
</name>
<name>
<surname>Childers</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Greenough</surname>
<given-names>W.T.</given-names>
</name>
</person-group>
<article-title>Calcium ion impedes translation initiation at the synapse</article-title>
<source/>J. Neurochem.
          <year>1996</year>
<volume>66</volume>
<fpage>197</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.1996.66010197.x</pub-id>
<pub-id pub-id-type="pmid">8522953</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-20-05539">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lur</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Haynes</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Prior</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Gerasimenko</surname>
<given-names>O.V.</given-names>
</name>
<name>
<surname>Feske</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>O.H.</given-names>
</name>
<name>
<surname>Burgoyne</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Tepikin</surname>
<given-names>A.V.</given-names>
</name>
</person-group>
<article-title>Ribosome-free terminals of rough ER allow formation of STIM1 puncta and segregation of STIM1 from IP(3) receptors</article-title>
<source/>Curr. Biol.
          <year>2009</year>
<volume>19</volume>
<fpage>1648</fpage>
<lpage>1653</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2009.07.072</pub-id>
<pub-id pub-id-type="pmid">19765991</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-20-05539">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myers</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Johnstone</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Dyment</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Epilepsy genetics: Current knowledge, applications, and future directions</article-title>
<source/>Clin. Genet.
          <year>2019</year>
<volume>95</volume>
<fpage>95</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1111/cge.13414</pub-id>
<pub-id pub-id-type="pmid">29992546</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-20-05539">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sherr</surname>
<given-names>E.H.</given-names>
</name>
</person-group>
<article-title>The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): One gene leads to many phenotypes</article-title>
<source/>Curr. Opin. Pediatr.
          <year>2003</year>
<volume>15</volume>
<fpage>567</fpage>
<lpage>571</lpage>
<pub-id pub-id-type="doi">10.1097/00008480-200312000-00004</pub-id>
<pub-id pub-id-type="pmid">14631200</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-20-05539">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abedini</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Kahrizi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Behjati</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Banihashemi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ghasemi Firoozabadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Najmabadi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Mutational screening of ARX gene in Iranian families with X-linked intellectual disability</article-title>
<source/>Arch. Iran. Med.
          <year>2012</year>
<volume>15</volume>
<fpage>361</fpage>
<lpage>365</lpage>
<pub-id pub-id-type="pmid">22642246</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-20-05539">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonneau</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Toutain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Laquerriere</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marret</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saugier-Veber</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Barthez</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Radi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Biran-Mucignat</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gelot</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>X-linked lissencephaly with absent corpus callosum and ambiguous genitalia (XLAG): Clinical, magnetic resonance imaging, and neuropathological findings</article-title>
<source/>Ann. Neurol.
          <year>2002</year>
<volume>51</volume>
<fpage>340</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1002/ana.10119</pub-id>
<pub-id pub-id-type="pmid">11891829</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-20-05539">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cossee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Faivre</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Philippe</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hichri</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>de Saint-Martin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Laugel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bahi-Buisson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lemaitre</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Leheup</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Delobel</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ARX polyalanine expansions are highly implicated in familial cases of mental retardation with infantile epilepsy and/or hand dystonia</article-title>
<source/>Am. J. Med. Genet. A
          <year>2011</year>
<volume>155a</volume>
<fpage>98</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.33785</pub-id>
<pub-id pub-id-type="pmid">21204215</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-20-05539">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olivetti</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Noebels</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Interneuron, interrupted: Molecular pathogenesis of ARX mutations and X-linked infantile spasms</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2012</year>
<volume>22</volume>
<fpage>859</fpage>
<lpage>865</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2012.04.006</pub-id>
<pub-id pub-id-type="pmid">22565167</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-20-05539">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stalpers</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Spruijt</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yntema</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Verrips</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Clinical phenotype of 5 females with a CDKL5 mutation</article-title>
<source/>J. Child Neurol.
          <year>2012</year>
<volume>27</volume>
<fpage>90</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1177/0883073811413832</pub-id>
<pub-id pub-id-type="pmid">21765152</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-20-05539">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nemos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Giuliano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Doray</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Roubertie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Goldenberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Delobel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Layet</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>N’Guyen</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Saunier</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutational spectrum of CDKL5 in early-onset encephalopathies: A study of a large collection of French patients and review of the literature</article-title>
<source/>Clin. Genet.
          <year>2009</year>
<volume>76</volume>
<fpage>357</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2009.01194.x</pub-id>
<pub-id pub-id-type="pmid">19793311</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-20-05539">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Shimojima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takayama</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Natsume</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shichiji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hirasawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okanishi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Okumura</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CDKL5 alterations lead to early epileptic encephalopathy in both genders</article-title>
<source/>Epilepsia
          <year>2011</year>
<volume>52</volume>
<fpage>1835</fpage>
<lpage>1842</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03174.x</pub-id>
<pub-id pub-id-type="pmid">21770923</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-20-05539">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saitsu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Osaka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsurusaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Doi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>A girl with early-onset epileptic encephalopathy associated with microdeletion involving CDKL5</article-title>
<source/>Brain Dev.
          <year>2012</year>
<volume>34</volume>
<fpage>364</fpage>
<lpage>367</lpage>
<pub-id pub-id-type="doi">10.1016/j.braindev.2011.07.004</pub-id>
<pub-id pub-id-type="pmid">21802232</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-20-05539">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kilstrup-Nielsen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rusconi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>La Montanara</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ciceri</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bergo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bedogni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy</article-title>
<source/>Neural Plast.
          <year>2012</year>
<volume>2012</volume>
<fpage>728267</fpage>
<pub-id pub-id-type="doi">10.1155/2012/728267</pub-id>
<pub-id pub-id-type="pmid">22779007</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-20-05539">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stouffer</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Golden</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Neuronal migration disorders: Focus on the cytoskeleton and epilepsy</article-title>
<source/>Neurobiol. Dis.
          <year>2016</year>
<volume>92</volume>
<fpage>18</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2015.08.003</pub-id>
<pub-id pub-id-type="pmid">26299390</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-20-05539">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srivastava</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pevsner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Aradhya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McKnight</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fatemi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A novel variant in GABRB2 associated with intellectual disability and epilepsy</article-title>
<source/>Am. J. Med. Genet. A
          <year>2014</year>
<volume>164a</volume>
<fpage>2914</fpage>
<lpage>2921</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36714</pub-id>
<pub-id pub-id-type="pmid">25124326</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-20-05539">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urak</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Feucht</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fathi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hornik</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity</article-title>
<source/>Hum. Mol. Genet.
          <year>2006</year>
<volume>15</volume>
<fpage>2533</fpage>
<lpage>2541</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddl174</pub-id>
<pub-id pub-id-type="pmid">16835263</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-20-05539">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macdonald</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.Q.</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Mutations in GABAA receptor subunits associated with genetic epilepsies</article-title>
<source/>J. Physiol.
          <year>2010</year>
<volume>588</volume>
<fpage>1861</fpage>
<lpage>1869</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2010.186999</pub-id>
<pub-id pub-id-type="pmid">20308251</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-20-05539">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doty</surname>
<given-names>C.N.</given-names>
</name>
</person-group>
<article-title>SCN9A: Another sodium channel excited to play a role in human epilepsies</article-title>
<source/>Clin. Genet.
          <year>2010</year>
<volume>77</volume>
<fpage>326</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2009.01366_1.x</pub-id>
<pub-id pub-id-type="pmid">20095983</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-20-05539">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meisler</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Sharkey</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Sodium channel gene family: Epilepsy mutations, gene interactions and modifier effects</article-title>
<source/>J. Physiol.
          <year>2010</year>
<volume>588</volume>
<fpage>1841</fpage>
<lpage>1848</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2010.188482</pub-id>
<pub-id pub-id-type="pmid">20351042</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-20-05539">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Pappas</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dahle</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Pruess</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>De Jonghe</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gurnett</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Peiffer</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome</article-title>
<source/>PLoS Genet.
          <year>2009</year>
<volume>5</volume>
<elocation-id>e1000649</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000649</pub-id>
<pub-id pub-id-type="pmid">19763161</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-20-05539">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heron</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Edkins</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>Scheffer</surname>
<given-names>I.E.</given-names>
</name>
<name>
<surname>Berkovic</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Mulley</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Neonatal seizures and long QT syndrome: A cardiocerebral channelopathy?</article-title>
<source/>Epilepsia
          <year>2010</year>
<volume>51</volume>
<fpage>293</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2009.02317.x</pub-id>
<pub-id pub-id-type="pmid">19863579</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-20-05539">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Grosveld</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Spanopoulou</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Tissue-specific control elements of the Thy-1 gene</article-title>
<source/>EMBO J.
          <year>1990</year>
<volume>9</volume>
<fpage>833</fpage>
<lpage>840</lpage>
<pub-id pub-id-type="doi">10.1002/j.1460-2075.1990.tb08180.x</pub-id>
<pub-id pub-id-type="pmid">1968831</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-20-05539">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caroni</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Overexpression of growth-associated proteins in the neurons of adult transgenic mice</article-title>
<source/>J. Neurosci. Methods
          <year>1997</year>
<volume>71</volume>
<fpage>3</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0270(96)00121-5</pub-id>
<pub-id pub-id-type="pmid">9125370</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-20-05539">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>An overview of transgenic mouse production</article-title>
<source/>Methods Mol. Biol.
          <year>1993</year>
<volume>18</volume>
<fpage>111</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="pmid">21390649</pub-id>
</element-citation>
</ref>
<ref id="B69-ijms-20-05539">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ting</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Soler-Llavina</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cobbs</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lein</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method</article-title>
<source/>J. Vis. Exp.
          <year>2018</year>
<pub-id pub-id-type="doi">10.3791/53825</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-20-05539">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarazona</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Furio-Tari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Turra</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pietro</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Nueda</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Ferrer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Conesa</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Data quality aware analysis of differential expression in RNA-seq with NOISeq R/Bioc package</article-title>
<source/>Nucleic Acids Res.
          <year>2015</year>
<volume>43</volume>
<fpage>e140</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv711</pub-id>
<pub-id pub-id-type="pmid">26184878</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-20-05539">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.G.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q.Y.</given-names>
</name>
</person-group>
<article-title>clusterProfiler: An R package, for comparing biological themes among gene clusters</article-title>
<source/>Omics
          <year>2012</year>
<volume>16</volume>
<fpage>284</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>
<pub-id pub-id-type="pmid">22455463</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-20-05539">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edgar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Domrachev</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lash</surname>
<given-names>A.E.</given-names>
</name>
</person-group>
<article-title>Gene Expression Omnibus: NCBI gene expression and hybridization array data repository</article-title>
<source/>Nucleic Acids Res.
          <year>2002</year>
<volume>30</volume>
<fpage>207</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id>
<pub-id pub-id-type="pmid">11752295</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-20-05539-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Changes in Ca<sup>2+</sup> responses in the hippocampal neurons overexpressing <italic>ORAI1</italic> calcium channel (<bold>A</bold>–<bold>D</bold>) or stromal interaction molecule 2 (<italic>STIM2</italic>) (<bold>E</bold>–<bold>G</bold>) compared with wild-type neurons. Ca<sup>2+</sup> measurements were performed using Fura-2 acetomethyl ester (Fura-2 AM) indicator that was loaded into the CA1 pyramidal neurons of the hippocampal acute brain slices (<bold>H</bold>). Typically, ~20 pyramidal neurons per one slice (n) were analyzed; the slices were isolated from at least 5 animals per genetic variant. The total number of slices analyzed per each genetic variant was 9. (<bold>A</bold>,<bold>E</bold>) Averaged time-course of background-subtracted fluorescence signal (expressed as F340/F380) from slices overexpressing <italic>ORAI1</italic> and <italic>STIM2</italic>, respectively. (<bold>B</bold>,<bold>F</bold>) Quantification of signal amplitudes observed following glutamate, cyclopiazonic acid (CPA), and Ca<sup>2+</sup> (re)addition in <italic>ORAI1</italic> and <italic>STIM2</italic> overexpressing neurons, respectively, arbitrary units (a.u.). (<bold>C</bold>,<bold>G</bold>) Quantification of F340/F380 values at baseline (average of 0–5th min of the measurement) and following application of ethylene glycol-bis(β-aminoethyl ether)-<italic>N</italic>,<italic>N</italic>,<italic>N</italic>′,<italic>N</italic>′-tetraacetic acid (EGTA) (at 13th and 25th min of the measurement) in <italic>ORAI1</italic> and <italic>STIM2</italic> overexpressing neurons, respectively, a.u. (<bold>D</bold>) Time-course of signal decay following glutamate application in <italic>ORAI1</italic> and wild-type neurons that was fit by a logarithmic function. Student’s <italic>t</italic>-test was used to check statistical significance of the observed differences; p-values are displayed above the respective charts.</p>
</caption>
<graphic xlink:href="ijms-20-05539-g001"></graphic>
</fig>
<fig id="ijms-20-05539-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>RNA sequencing (RNAseq) analysis using Noiseq tools based on data gathered from hippocampi of wild-type and FVB/NJ-Tg(ORAI1)Ibd females. (<bold>A</bold>) Dot plot of Gene Ontology Biological Process groups (GO BP), which are down-regulated and up-regulated in transgenic line (on the left and right, respectively). (<bold>B</bold>) Volcano plot represents differential gene expression between the tested variants. (<bold>C</bold>) Principal component analysis (PCA) of principal component 1 (PC1) and 2 (PC2). Transgenic and wild-type mice are color-coded in green and red, respectively. PCA analysis was carried out from FPKM (Fragments Per Kilobase Million) normalized RNAseq data using prcomp function in R software.</p>
</caption>
<graphic xlink:href="ijms-20-05539-g002"></graphic>
</fig>
<fig id="ijms-20-05539-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Expression profile of selected genes in hippocampi of the tested mouse variants. (<bold>A</bold>) Rea-time PCR analysis of the selected genes that was based on RNAseq data. The results are presented as scatter plot, each circle corresponds to one animal. Black circle corresponds to each tested wild-type probe, whereas green corresponds to transgenic ones. The obtained results suggest a down-regulation of expression of <italic>Arx</italic>, <italic>Cdkl5,</italic> and <italic>Dclk1</italic>. The data are presented as a fold change (2<sup>−∆∆Ct</sup>) normalized to the three reference genes (<italic>Uba-2</italic>, <italic>Gapdh</italic>, <italic>Actin</italic>). The statistics was estimated by CFX software (Bio-Rad) using the post hoc method (Tukey’s test). (<bold>B</bold>) The ddPCR analysis of <italic>Arx</italic>, <italic>Cdkl5</italic>, <italic>Dclk1</italic> using customized assays (Bio-Rad). The number of transcript copies of the selected genes are presented in relation to 1000 copies of the reference gene <italic>Uba-2</italic>. The results are presented as dot plot, where each sign corresponds to an individual animal (3 wild-type, 6 transgenic). The statistics were calculated by GraphPad Prism software using unpaired <italic>t</italic>-test. The number of <italic>Arx</italic> transcripts was about 30 times lower than that of <italic>Cdkl5</italic> and <italic>Dclk1</italic>, therefore, it is presented on a separate chart.</p>
</caption>
<graphic xlink:href="ijms-20-05539-g003"></graphic>
</fig>
<fig id="ijms-20-05539-f004" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>Expression profile of the selected genes in the hippocampi of the tested mouse variants that was obtained by real-time PCR analysis. The results are presented as scatter plot; each circle corresponds to one animal. The obtained results suggest an up-regulation of the expression of <italic>Hes-5</italic> and <italic>Strap</italic>. The data are presented as a fold change (2<sup>−∆∆Ct</sup>) that was normalized to the reference gene (<italic>Uba-2</italic>), the statistics was estimated by CFX software (Bio-Rad) using post hoc method (Tukey’s test).</p>
</caption>
<graphic xlink:href="ijms-20-05539-g004"></graphic>
</fig>
<table-wrap id="ijms-20-05539-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-20-05539-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>A list of selected genes that were chosen for validation using customized arrays. <italic>Arx, Dclk1</italic>, <italic>Cdkl5</italic> and were subsequently taken to ddPCR analysis (framed in green).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin" valign="middle">
</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Bio-Rad Assays</th>
<th align="center" colspan="2" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">qPCR</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gene Name</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ENSEMBL ID</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Description</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cat. No.</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2<sup>−∆∆Ct</sup></th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>p</italic>-Value Tukey</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="6" style="border-bottom:solid thin" valign="middle">Genes associated with epilepsy</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Kcne2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000039672</td>
<td align="center" colspan="1" rowspan="1" valign="middle">potassium voltage-gated channel, Isk-related subfamily, gene 2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0011027</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin #80C687" valign="middle">0.487</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin #80C687" valign="middle">0.670</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Arx</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000035277</td>
<td align="center" colspan="1" rowspan="1" valign="middle">aristaless related homeobox</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCED0004831</td>
<td align="center" colspan="1" rowspan="1" style="border-left:solid thin #80C687" valign="middle">0.787</td>
<td align="center" colspan="1" rowspan="1" style="border-right:solid thin #80C687" valign="middle">0.046</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Dclk1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000027797</td>
<td align="center" colspan="1" rowspan="1" valign="middle">serine/threonine-protein kinase DCLK1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0022222</td>
<td align="center" colspan="1" rowspan="1" style="border-left:solid thin #80C687" valign="middle">0.827</td>
<td align="center" colspan="1" rowspan="1" style="border-right:solid thin #80C687" valign="middle">0.015</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Cdkl5</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000031292</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cyclin-dependent kinase-like 5</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0013381</td>
<td align="center" colspan="1" rowspan="1" style="border-left:solid thin #80C687;border-bottom:solid thin #80C687" valign="middle">0.868</td>
<td align="center" colspan="1" rowspan="1" style="border-right:solid thin #80C687;border-bottom:solid thin #80C687" valign="middle">0.064</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Gabrb2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000007653</td>
<td align="center" colspan="1" rowspan="1" valign="middle">gamma-aminobutyric acid (GABA) A receptor, subunit beta 2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0005334</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.886</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.224</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>Scn9a</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ENSMUSG00000075316</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">sodium channel protein type 9 subunit alpha</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">qMmuCID0015354</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1.283</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.131</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Folr1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000001827</td>
<td align="center" colspan="1" rowspan="1" valign="middle">folate receptor 1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0016330</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.5262</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.688</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Clic6</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000022949</td>
<td align="center" colspan="1" rowspan="1" valign="middle">chloride intracellular channel 6</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0011099</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.615</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.678</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Kl</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000058488</td>
<td align="center" colspan="1" rowspan="1" valign="middle">klotho, the Klotho peptide generated by cleavage of the membrane-bound isoform may be an anti-aging circulating hormone</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0007154</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.663</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.648</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Trpm3</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000052387</td>
<td align="center" colspan="1" rowspan="1" valign="middle">transient receptor potential cation channel, subfamily M, member 3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0040163</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.8</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.747</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Fam26e</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000049872</td>
<td align="center" colspan="1" rowspan="1" valign="middle">calcium homeostasis modulator protein 5</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0008059</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.882</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.213</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Cul4b</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000031095</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cullin 4B, Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0011478</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.884</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.667</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Mmp14</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000000957</td>
<td align="center" colspan="1" rowspan="1" valign="middle">matrix metallopeptidase 14 (membrane-inserted)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0006120</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.889</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.473</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Ston2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000020961</td>
<td align="center" colspan="1" rowspan="1" valign="middle">stonin 2, adapter protein involved in endocytic machinery</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0014604</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.936</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.462</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Shisa9</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000022494</td>
<td align="center" colspan="1" rowspan="1" valign="middle">regulator of short-term neuronal synaptic plasticity in the dentate gyrus</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0022663</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.940</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.523</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Akap9</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000040407</td>
<td align="center" colspan="1" rowspan="1" valign="middle">A-kinase anchor protein 9, scaffolding protein</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0023460</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.958</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.542</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Enah</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000022995</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENAH actin regulator; actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0026581</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.985</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.593</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Nrp2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000025969</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Neuropilin-2, High affinity receptor for semaphorins</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0005743</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.021</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.835</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Mdm2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000020184</td>
<td align="center" colspan="1" rowspan="1" valign="middle">E3 ubiquitin-protein ligase</td>
<td align="center" colspan="1" rowspan="1" valign="middle">qMmuCID0025320</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.044</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.676</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>Prex2</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ENSMUSG00000048960</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">qMmuCID0039899</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1.070</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.187</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="ijms-20-05539-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-20-05539-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>List of selected genes together with primers sequence whose expression profile was analyzed using real-time PCR. Up-regulation of hairy and enhancer of split-5 (<italic>Hes-5)</italic>, a transcriptional repressor, was detected in the hippocampus of Tg(ORA1)Ibd line (highlighted in green).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
</th>
<th align="center" colspan="2" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Primer sequence</th>
<th align="center" colspan="2" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">qPCR</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gene Name</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ENSEMBL ID</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Description</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Forward</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Revers</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2<sup>−∆∆Ct</sup></th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>p</italic>-Value Tukey</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Ddb1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000024740</td>
<td align="center" colspan="1" rowspan="1" valign="middle">damage specific DNA binding protein 1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TCAAAGAGGTGGGAATGTACG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">GATGTCAATGCTTTCGCCAC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.147</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.351</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Vdac2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000021771</td>
<td align="center" colspan="1" rowspan="1" valign="middle">voltage-dependent anion channel 2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TGGAACACCGATAACACTCTG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CACTCCCTCTTGTAAGCAGAC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.18</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.317</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Cul1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000029686</td>
<td align="center" colspan="1" rowspan="1" valign="middle">cullin 1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ACCGATTCTCCAGCAAAGTG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TCTCCATGTCACCAATGCAAG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.204</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.400</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Nol3</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000014776</td>
<td align="center" colspan="1" rowspan="1" valign="middle">nucleolar protein 3 (apoptosis repressor with CARD domain)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TCCAAGAAGAGGATGAATCTGAAG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ATTTGGCAGTAGGTGTCTCG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.298</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.255</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Itmbl2</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000022108</td>
<td align="center" colspan="1" rowspan="1" valign="middle">integral membrane protein 2B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TTTGAGGAAGACGCAGTGG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TGTTCAGAGGAATCACGTAG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.396</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.272</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Clnx</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000020368</td>
<td align="center" colspan="1" rowspan="1" valign="middle">calnexin</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CTTTGCCAGTGTTCCTTGTG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CTTCCTCTTCATCCCTCTTGTTC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.495</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.534</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Sv2a</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000038486</td>
<td align="center" colspan="1" rowspan="1" valign="middle">synaptic vesicle glycoprotein 2 a</td>
<td align="center" colspan="1" rowspan="1" valign="middle">GTGGACACTCTACTTCGTGC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ATGCCCAGGTACACAATGAG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.502</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.395</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Gpr17</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000052229</td>
<td align="center" colspan="1" rowspan="1" valign="middle">G protein-coupled receptor 17</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TCTCCTGTCCTTTCCTTCCT</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TCTCTTGTCCGCATTGCTC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.587</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.117</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Arc</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000022602</td>
<td align="center" colspan="1" rowspan="1" valign="middle">activity regulated cytoskeletal-associated protein</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CTACAGAGCCAGGAGAATGAC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">GTGTCTTGGAACCCATGTAGG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.752</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.668</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Rab5</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000000711</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Rab5B. member RAS oncogene family</td>
<td align="center" colspan="1" rowspan="1" valign="middle">AGGGAACAAAGCTGACCTTG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TGCCAGGAAGAGATCATTCAC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.820</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.505</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Atxn</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000074748</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ataxin 7-like 3B</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TGTGTACCCAGCCTATACAATTC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CCTGACCATCAACACCATCTAA</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.906</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.865</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>TIMP1</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000001131</td>
<td align="center" colspan="1" rowspan="1" valign="middle">tissue inhibitor of metalloproteinase 1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CTCAAAGACCTATAGTGCTGGC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CAAAGTGACGGCTCTGGTAG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.913</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.890</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Dok3</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000035711</td>
<td align="center" colspan="1" rowspan="1" valign="middle">docking protein 3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ACTGGTGCCTTCCTGATTAC</td>
<td align="center" colspan="1" rowspan="1" valign="middle">GATCCTGACGAACATTCTCCG</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.961</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.949</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>Strap</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ENSMUSG00000030224</td>
<td align="center" colspan="1" rowspan="1" valign="middle">serine/threonine kinase receptor associated protein</td>
<td align="center" colspan="1" rowspan="1" valign="middle">CCAGGGAGATACAGGAGACT</td>
<td align="center" colspan="1" rowspan="1" valign="middle">AGACCGCATCCCATACTTTG</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin #80C687" valign="middle">1.568</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin #80C687" valign="middle">0.186</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>Hes-5</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ENSMUSG00000048001</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">hes family bHLH transcription factor 5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CTACCTGAAACACAGCAAAGC</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin;border-right:solid thin #80C687" valign="middle">AGCTTCATCTGCGTGTCG</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin #80C687" valign="middle">2.932</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin #80C687;border-right:solid thin #80C687" valign="middle">0.003</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="ijms-20-05539-t003" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-20-05539-t003_Table 3</object-id>
<label>Table 3</label>
<caption>
<p>Phenotypes of human mutations of genes which are associated with epilepsy.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene Name</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Encoded Protein Function</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Phenotype in Human</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>Arx</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">aristaless related homeobox gene- regulator of gene transcription important forbrain development</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Early infantile epileptic encephalopathy (EIEE);<break></break> X-linked lissencephaly with abnormal genitalia (XLAG)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B48-ijms-20-05539">48</xref>,<xref ref-type="bibr" rid="B49-ijms-20-05539">49</xref>,<xref ref-type="bibr" rid="B50-ijms-20-05539">50</xref>,<xref ref-type="bibr" rid="B51-ijms-20-05539">51</xref>,<xref ref-type="bibr" rid="B52-ijms-20-05539">52</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>Cdkl5</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">X-linked serine/threonine kinase cyclin-dependent kinase-like 5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Early infantile epileptic encephalopathy (EIEE)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B53-ijms-20-05539">53</xref>,<xref ref-type="bibr" rid="B54-ijms-20-05539">54</xref>,<xref ref-type="bibr" rid="B55-ijms-20-05539">55</xref>,<xref ref-type="bibr" rid="B56-ijms-20-05539">56</xref>,<xref ref-type="bibr" rid="B57-ijms-20-05539">57</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>Dclk1</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">doublecortin-like kinase 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Focal seizures</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B58-ijms-20-05539">58</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>Gabrb2</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">subunit of γ-aminobutyric acid type A (GABAA) receptor</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Generalized epilepsy with febrile seizures plus (GEFS+); Childhood absence epilepsy (CAE); Lennox-Gastaut syndrome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B59-ijms-20-05539">59</xref>,<xref ref-type="bibr" rid="B60-ijms-20-05539">60</xref>,<xref ref-type="bibr" rid="B61-ijms-20-05539">61</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>Scn9a</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">sodium channel</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dravet syndrome (DS); Familial febrile seizures (FFS); Generalized epilepsy with febrile seizures plus (GEFS+)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B62-ijms-20-05539">62</xref>,<xref ref-type="bibr" rid="B63-ijms-20-05539">63</xref>,<xref ref-type="bibr" rid="B64-ijms-20-05539">64</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>Kcne</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">a family of single-helix transmembrane proteins with 5 known members that modulate the function of several ion channels</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Familial neonatal seizures</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B65-ijms-20-05539">65</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>